Indrayani Biotech Peer Comparison

BSE: 526445

₹8.39

₹-0.10 (-1.18%)

As on 14-Oct-2026IST

Market cap

₹38 Cr

Revenue (TTM)

₹181 Cr

P/E Ratio

18.2

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Market cap (₹ Cr)	38	9,589	297	222	60
Revenue (₹ Cr)	181	23,506	82	434	67
Net Profit (₹ Cr)	2.66	553.62	10.62	17.44	-7.30
Net Margin (%)	1.42	2.35	12.59	3.90	0.51
RoE (%)	2.82	10.18	9.30	6.80	-47.21
Price to Earnings	18.22	17.32	27.91	12.72	--
Price-To-Book	0.52	1.54	2.38	0.85	24.33

Income Statement (₹ Cr)

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Operating Revenue	181.45	23,506.20	82.15	433.83	67.24
Total Income	187.39	23,565.09	84.39	446.74	69.21
Total Expenditure	169.74	21,906.92	64.51	403.95	63.58
EBITDA	11.70	1,599.28	17.64	29.89	3.67
Depreciation	5.55	202.34	4.36	10.72	3.37
EBIT	6.16	1,396.94	13.29	19.17	0.30
Interest	11.27	676.51	0.38	13.08	2.04
Other Income	5.94	58.89	2.25	12.91	1.96
Exceptional Items	0.00	-58.78	-0.60	0.00	0.00
Profit before Tax	0.82	720.54	14.56	18.99	0.22
Provision for Tax	-1.84	166.92	3.93	1.55	-0.13
Profit after Tax	2.66	553.62	10.62	17.44	0.35

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Shareholder's Funds	72.89	6,159.69	122.45	257.94	2.31
Minority Interest	-0.56	0.00	0.00	0.00	0.00
Non-Current Liabilities	58.36	990.55	2.84	58.41	8.14
Current Liabilities	92.98	18,007.82	9.40	236.55	58.01
Total Liabilities	267.94	22,164.37	127.18	526.89	67.56

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Non-Current Assets	89.67	2,057.25	65.46	277.80	36.25
Current Assets	158.72	22,209.08	59.07	249.09	29.17
Total Assets	267.94	22,164.37	127.18	526.89	67.56
Total Debt*	137.07	3,701.10	6.35	139.02	27.63
Net Current Assets	65.74	4,201.26	49.67	12.55	-28.84
Contingent Liabilities	--	179.24	2.63	15.96	4.49

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Cash From Operating Activities	-6.74	419.07	11.60	7.70	1.06
Cash Flow from Investing Activities	24.74	-67.87	-11.76	-6.56	0.20
Cash from Financing Activities	-18.30	-32.12	1.84	-2.92	-1.43
Net Cash Inflow / Outflow	-0.29	319.08	1.67	-1.78	-0.17

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
ROCE (%)	3.19	18.50	9.72	10.22	3.32
ROE (%)	2.82	10.18	9.30	6.80	-47.21
ROA (%)	1.02	2.34	7.98	3.27	0.52
EBIT Margin (%)	3.39	5.94	16.17	4.42	0.44
Net Margin (%)	1.42	2.35	12.59	3.90	0.51
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Revenue Growth (%)	41.97	5.14	14.86	-2.88	13.95
EBIT Growth (%)	475.77	-0.26	51.89	-4.16	-44.78
Net Profit Growth (%)	139.09	-8.91	39.89	-43.90	202.91
EPS Growth (%)	127.87	-1.20	45.81	-15.97	-158.86
Book Value Growth (%)	9.39	30.56	3.36	12.75	-45.64

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Price / Earnings	18.24	15.97	26.78	12.71	-20.72
Price / Book Value	0.52	1.54	2.38	0.85	24.33
Dividend Yield (%)	0.00	1.53	0.40	0.00	0.00
EV/EBITDA	14.95	8.87	15.83	12.29	26.81
Market Cap (₹ Cr)	64.93	20,830.83	141.26	205.41	60.84

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Debt to Equity	0.79	0.11	0.02	0.13	2.00
Short term debt to equity ratio	0.97	0.60	0.03	0.41	1.76
Current Ratio	1.71	1.23	6.28	1.05	0.50
Quick Ratio	1.30	1.15	4.84	0.60	0.36
Interest Coverage	1.07	2.07	39.41	2.45	1.11

	Indrayani Biotech	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf
Debtors to sales (%)	32.28	27.54	26.98	14.56	18.22
Asset Turnover	0.70	0.99	0.62	0.81	0.99
Receivable days	137.64	76.75	91.99	37.44	110.88
Inventory Days	117.29	19.66	67.73	76.25	89.59
Payable days	134.44	237.22	166.81	124.30	203.97
Cash Conversion Cycle	120.49	-140.81	-7.10	-10.61	-3.51

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.